期刊文献+

食管癌临床分期与病理分期分布合理性和预后判断价值比较 被引量:12

Comparison of rationality and prognostic value between clinical staging and pathological staging for esophageal cancer
原文传递
导出
摘要 目的 通过与术后病理分期标准的比较,探讨《非手术治疗食管癌的临床分期标准(草案)》的分布合理性及判断预后的价值.方法 回顾分析2009-2012年间本院根治手术或术后辅助治疗的162例食管癌患者临床资料,对其进行术前临床分期及术后病理分期,并采用Kappa法分析两种分期间各期病例分布一致性.Kaplan-Meier法计算OS率并Logrank法检验差异和单因素分析.结果 T、N、TNM分期总符合率分别为67.9%、57.4%、67.9%,一致性程度分别为中等、较差、中等(Kappa=0.544、0.302、0.509).随访率为93.2%,1、2、3年样本数分别为127、66、27例.全组1、2、3年OS率分别为82.6%、56.2%、37.7%.术前除了T1与T2期、N0与N1期OS相近外(P=0.086、0.101),T、N、TNM分期各期间OS均不同(P =0.000 ~0.028),与术后病理分期对预后判断的预示作用一致.结论 《非手术治疗食管癌的临床分期标准(草案)》的分布合理性一般,预后判断价值较好,但仍需进一步细化和完善. Objective To investigate the rationality and prognostic value of the Criteria for clinical staging of esophageal cancer treated by non-surgical methods (Draft) by comparison with the criteria for postoperative pathological staging.Methods A retrospective analysis was performed on the clinical data of 162 patients with esophageal cancer who underwent radical resection at the Second Hospital of Soochow University from December 2008 to July 2012.Preoperative clinical staging and postoperative pathological staging were performed,and the Kappa statistic was used to evaluate the agreement between the two staging systems.The Kaplan-Meier method was used to calculate overall survival (OS) rates,and the log-rank test was used for survival difference analysis and univariate analysis.Results The coincidence rates of T,N,and TNM stages were 67.9%,57.4%,and 67.9%,respectively,and the agreements were moderate,poor,and moderate,with Kappa values of 0.544,0.302,and 0.509.The follow-up rate was 93.2%.The 1-,2-,and 3-year sample sizes were 127,66 and 27,respectively.The 1-,2-,and 3-year OS rates were 82.6%,56.2%,and 37.7%,respectively.There were no significant differences in OS between patients with preoperative T1 and T2 stages and between patients with preoperative N0 and N1 stages (P =0.086,0.101),but significant differences were observed between patients with different T stages,N stages,or TNM stages (P =0.000-0.028).This was in line with the prognostic results based on the postoperative pathological staging.Conclusions The clinical staging criteria (draft) have moderate agreement with the criteria for postoperative pathological staging and have good prognostic value,but they require further refinement and improvement.
出处 《中华放射肿瘤学杂志》 CSCD 北大核心 2014年第4期307-311,共5页 Chinese Journal of Radiation Oncology
关键词 食管肿瘤 临床分期 病理分期 预后价值 Esophageal neoplasms Clinical stage Pathological stage Predictive value
  • 相关文献

参考文献5

二级参考文献25

  • 1祝淑钗,李任,王玉祥,李娟,邱嵘.500例中晚期食管癌单纯放疗的多因素分析[J].中华放射肿瘤学杂志,2005,14(4):253-258. 被引量:68
  • 2Thompson WM,Halvorsen RA,Foster WL Jr,et al.Computed tomography for staging esophageal and gastroesophageal cancer:reevaluation.AJR Am J Roentgenol,1983,141:951-958.
  • 3Picus D,Balfe M,Koehler RE,et al.Computed tomagraphy in the staging of esophageal carcinoma.Radiology,1983,146:433-438.
  • 4刘泰福.现代放射肿瘤学.上海:上海医科大学出版社,2008.
  • 5Takashima S,Takeuchi N,Shiozaki H,et al.Carcinoma of the osophagus:CT vs MR imaging in determining resectability.AJR Am J Roentgenol,1991,156:297-302.
  • 6麻国新,万钧.早期食管癌的放射治疗//万钧,韩春,刘惠明.食管癌的放射治疗.2版.北京:原子能出版社,2006:161-166.
  • 7Rice TW,Rusch VW,Apperson-Hansen C,et al.Worldwide esophageal cancer collaboration[J].Dis Esophagus,2009,22 (1):128.
  • 8Eloubeidi MA,Desmond R,Arguedas MR,et al.Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.:the importance of tumor length and lymph node status[J].Cancer,2002,95(7):1434-1443.
  • 9Sobin LH,Wittekind C.TNM classification of malignant tumors[M]//International Union Against Cancer.Oesophagus.6th ed.New York:Wile-Liss,2002:60-64.
  • 10Yoon YC,Lee KS,Shim YM,et al.Metastasis to regional lymphnodes in patients with esophageal squamous cell carcinoma:CT rersus FDG PET for presurgical detection prospective study[J].Radiology,2003,227 (3):764-770.

共引文献279

同被引文献128

引证文献12

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部